Business Segments

3 Months Ended

Apr. 01, 2023

Segment Reporting [Abstract]

Business Segments

12. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows (in thousands):

	Three Months Ended
	April 1, 2023		April 2, 2022
Cyclo G6	$	3,669	$	3,540
Retina		7,214		7,301
Other(1)		2,823		2,546
Total revenues	$	13,706	$	13,387

(1) Includes service contract revenues of $383 thousand and $362 thousand recognized during the three months ended April 1, 2023 and April 2, 2022, respectively. Includes $364 thousand and $277 thousand recognized revenue related to the exclusive

distribution rights during the three months ended April 1, 2023 and April 2, 2022, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows (in thousands):

	Three Months Ended
	April 1, 2023		April 2, 2022
United States	$	6,774	$	6,543
Europe, Middle East and Africa		4,177		3,431
Asia/Pacific Rim		2,143		2,853
Rest of Americas		612		560
Total revenues	$	13,706	$	13,387

Revenues are attributed to countries based on the location of end customers.

Other than the United States, the Netherlands accounted for at least 10% of the Company’s revenues during the three months ended April 1, 2023, representing 16%. Other than the United States, Japan and the Netherlands accounted for at least 10% of the Company’s revenues during the three months ended April 2, 2022, representing 12% and 10%, respectively. The United States accounted for 49.4% and 48.9% of revenues for the three months ended April 1, 2023 and April 2, 2022, respectively.